Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 2 | ClinicalTrials |
| Narcolepsy; Sleepiness | Phase 3 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Sarcoma; Sarcoma, Ewing | Phase 2 | ClinicalTrials |
| Endometrial Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | Phase 2 | ClinicalTrials |
| Bone Neoplasms; Neoplasms; Neoplasms, Bone Tissue; Neoplasms by Histologic Type; Neoplasms, Connective and Soft Tissue; Neoplasms, Connective Tissue; Rare Diseases; Sarcoma; Sarcoma, Ewing | Phase 3 | ClinicalTrials |
| Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | Phase 2 | ClinicalTrials |
CONTENTS